This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Tue Jun 18, 2013 11:48 pm

View unanswered posts | View active topics


Board index » Treatments » Revimmune (cyclophosphamide or cytoxan)

All times are UTC - 8 hours [ DST ]



Post new topic Reply to topic  Page 1 of 2
  [ 17 posts ]  Go to page 1, 2  Next
  Print view Previous topic | Next topic 
Author Message
chrishasms
 Post subject: PUT YOURSELF UP HERE
PostPosted: Wed Sep 26, 2007 7:40 am 
Offline
Family Elder

Joined: Thu Sep 14, 2006 3:00 pm
Posts: 1161
123


Last edited by chrishasms on Sun Dec 06, 2009 1:39 pm, edited 1 time in total.

Top
 Profile  
 
Lyon
 Post subject:
PostPosted: Wed Sep 26, 2007 5:01 pm 
Offline
Family Elder

Joined: Wed May 03, 2006 3:00 pm
Posts: 6063
HI CHRIS!

The suggestion of this thread was a good idea, although it's a little early so I wouldn't expect too much "bidness" just yet :lol:
Bob
Top
 Profile  
 
chrishasms
 Post subject:
PostPosted: Fri Sep 28, 2007 9:05 pm 
Offline
Family Elder

Joined: Thu Sep 14, 2006 3:00 pm
Posts: 1161
123


Last edited by chrishasms on Sun Dec 06, 2009 1:40 pm, edited 1 time in total.

Top
 Profile  
 
MaggieMae
 Post subject:
PostPosted: Mon Oct 01, 2007 6:04 am 
Offline
Family Elder
User avatar

Joined: Wed May 23, 2007 3:00 pm
Posts: 376
Location: Pennsylvania
Chris,

Glad you started this page. I'm watching (hopefully).
Top
 Profile  
 
MaggieMae
 Post subject:
PostPosted: Wed Oct 03, 2007 8:42 am 
Offline
Family Elder
User avatar

Joined: Wed May 23, 2007 3:00 pm
Posts: 376
Location: Pennsylvania
Chris,

From what I read you are in the cyclophosphamide study at Stony Brook in New York under Dr. Douglas Gladstone. I found it under clincial trials NCT00296205. But, John Hopkins is doing the Revimmune trial (which is also a high dose cyclophosphamide) under a company called Accentia which purchased the license.

Can you explain the difference.
Top
 Profile  
 
MaggieMae
 Post subject:
PostPosted: Wed Oct 03, 2007 9:26 am 
Offline
Family Elder
User avatar

Joined: Wed May 23, 2007 3:00 pm
Posts: 376
Location: Pennsylvania
Chris,

I just e-mailed the name given on the government clinical trial web site for the cyclophosphamide study at Stony Brook (same one you gave on the Tovaxin page) and she said that Dr. Gladstone no longer works there and gave me a number to call for Dr. Gladstone. The study is also no longer being conducted at Stony Brook.

Reading back on your past post on the Tovaxin page, I realized (what you meant) when you said that the person you e-mailed gave you a number to call. Do you know what hospital he is affiliated with and where you will be receiving your treatment?
Top
 Profile  
 
Lyon
 Post subject:
PostPosted: Sat Oct 06, 2007 9:11 am 
Offline
Family Elder

Joined: Wed May 03, 2006 3:00 pm
Posts: 6063
Hi maggie,
Accentia is the company which bought the rights to high dose cyclophosphamide against the spectrum of autoimmune diseases and named it "Revimmune".

The situation you see looks mixed up from the outside but seems normal for researchers who started collaborating on a project and later go their separate ways, yet continue collaboration on the project.

In searching the internet it seems that Dr Gladstone started at Johns Hopkins (collaborating with HDC) and later went to Stony brook. I thought he was still at Stony brook until you mentioned it and now I notice that his last paper he is listed as being at Hematology Oncology Associates of Western Suffolk http://www.hemoncsuffolk.com/physicians ... one_md.php

In other words, what seems like multiple places working separately with HDC are (seemingly) working together, or at least in association.
Bob

Quote:
J Neuroimmunol. 2007 Sep 11; [Epub ahead of print]Click here to read Links
High dose cyclophosphamide preferentially targets naïve T (CD45/CD4/RA+) cells in CIDP and MS patients.
Gladstone DE, Golightly MG, Brannagan TH 3rd.

Hematology Oncology Associates of Western Suffolk, 24 East Main Street, Bay Shore, NY 11706, United States.

INTRODUCTION: T cells occupy a central role in MS and CIDP pathogenesis. High dose cyclophosphamide's in-vivo cytotoxic-effect on circulating memory and naïve T cells is unknown. METHOD: Three MS and five CIDP patients received cyclophosphamide (200 mg/kg) for refractory disease. Before and after chemotherapy administration, peripheral blood T-cell subsets were determined. Patients underwent serial neurologic evaluations quarterly. RESULTS: Cyclophosphamide uniformly decreased clinical disease activity. Compared to memory T cells, naïve T cells were preferentially eradicated. DISCUSSION: Cyclophosphamide effectiveness in autoimmune illness may result from Naïve T-cell destruction, as this compartment may be the source of autoreactive lymphocytes.

PMID: 17854912 [PubMed - as supplied by publisher]
Top
 Profile  
 
MaggieMae
 Post subject:
PostPosted: Mon Oct 08, 2007 10:03 am 
Offline
Family Elder
User avatar

Joined: Wed May 23, 2007 3:00 pm
Posts: 376
Location: Pennsylvania
Thanks for the explanation. I could not understand how Accentia could purchase the license; John Hopkins conduct the study; and Dr. Gladstone continue to administer the HDC. Now I understand. :)
Top
 Profile  
 
Lyon
 Post subject:
PostPosted: Mon Oct 08, 2007 12:30 pm 
Offline
Family Elder

Joined: Wed May 03, 2006 3:00 pm
Posts: 6063
That was admittedly a particularly hard situation to follow. If you noticed, Dr Gladstone's resume doesn't mention his time at Stony Brook. I don't know if that was an oversight, whether he left on bad terms or if he hadn't actually been a full staff member at Stony Brook during his time there.

Bob
Top
 Profile  
 
lgwright
 Post subject:
PostPosted: Thu Oct 11, 2007 11:23 am 
Offline
Getting to Know You...
User avatar

Joined: Wed Oct 03, 2007 3:00 pm
Posts: 11
Location: Indiana
How do I get in on this study?
Top
 Profile  
 
Lyon
 Post subject:
PostPosted: Thu Oct 11, 2007 7:29 pm 
Offline
Family Elder

Joined: Wed May 03, 2006 3:00 pm
Posts: 6063
Hi Larry,

I was holding off in hopes that we'd hear more information from Chris or Maggie but I'll try contacting Dr Gladstone with his old Stony Brook email address and at the same time I'll see what I can find out from Johns Hopkins.

Maggie mentioned something about a Revimmune clinical trial at Johns Hopkins, but no trials are listed under "revimmune" at the clinical trials site and Johns Hopkins only has scleroderma listed under "high dose cyclophosphamide".

Bob
Top
 Profile  
 
MaggieMae
 Post subject:
PostPosted: Fri Oct 12, 2007 5:50 am 
Offline
Family Elder
User avatar

Joined: Wed May 23, 2007 3:00 pm
Posts: 376
Location: Pennsylvania
Dr. Gladstone is no longer at Stony Brook. I was given a number (by Stony Brook) to call at his new institution. It is 631-666-6752. I don't think that Dr. Gladstone is under the Revimmune trial. That was part of what confused me. If Accentia bought the rights, how could he continue to administer the HDC to treat MS patients.

Check out the Accentia site for information on Revimmune. From what I read in various articles, it is going to be a multi-center trial. But, there is nothing listed to date under clinical trials. You could either get in touch with John Hopkins (Dr. Douglas Kerr) or Accentia.
Top
 Profile  
 
Lyon
 Post subject:
PostPosted: Fri Oct 12, 2007 6:19 am 
Offline
Family Elder

Joined: Wed May 03, 2006 3:00 pm
Posts: 6063
Thanks Maggie, I'll do that.

I tried Dr Gladstone's Stony Brook address but it came back as undeliverable. I got his new email address from his most recent article, but if he is no longer involved in the trial, he will soon be telling me what you just did.

I'll email Dr Kerr just to cover all bases.

Bob
Top
 Profile  
 
Lyon
 Post subject:
PostPosted: Fri Oct 12, 2007 12:26 pm 
Offline
Family Elder

Joined: Wed May 03, 2006 3:00 pm
Posts: 6063
Dr Gladstone responded so quickly I didn't have a chance to contact anyone at Johns Hopkins.
Bob

Quote:
The phase II trial is stopped at Stony Brook. But we expect the protocol to be opened in Bay Shore, Long Island within the next 60 days.

My new office contact number is 631 666 6752

doug gladstone
Top
 Profile  
 
MaggieMae
 Post subject:
PostPosted: Mon Oct 15, 2007 5:51 am 
Offline
Family Elder
User avatar

Joined: Wed May 23, 2007 3:00 pm
Posts: 376
Location: Pennsylvania
My husband is to start Tysabri. He just got his script for an MRI and blood work because that is what is available to him and his doctor thinks it may help to keep him walking (his walking is limited) until something better comes along. I'm so afraid because I have read that some people on Tysabri do worse.

Since Tovaxin isn't an option for him (at this time), I can't help but wonder if we shouldn't be trying to get into the Revimmune Trial or travel to New York to see Dr. Gladstone. This would not be easy for us because of obligations I have to others in our family with health problems. I don't know....
Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  Page 1 of 2
  [ 17 posts ]  Go to page 1, 2  Next

Board index » Treatments » Revimmune (cyclophosphamide or cytoxan)

All times are UTC - 8 hours [ DST ]

Who is online

Users browsing this forum: No registered users

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to:  


News News Site map Site map SitemapIndex SitemapIndex RSS Feed RSS Feed Channel list Channel list
Read hundreds of personal Multiple Sclerosis stories on Experience Project. Experience Project is an anonymous community where people connect through their life experiences, made by the same people who built This is MS. With over 30 million personal stories about every possible life experience, you can quickly find people like you!


Interesting: Secret Confessions | Dream Meanings | Ask Questions, Get Answers
This site does not offer, or claim to offer, medical, legal, or professional advice. All treatment decisions should always be made with the full knowledge of your physicians.


All logos and trademarks in this site are property of their respective owners. Content is © 2002-2013 by thisisMS.com.

Advertise on the premier multiple sclerosis forum